Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool February 7, 2008 Rich Smith	I Spy OSI OSI, the airport security checkpoint equipment manufacturer, beats analyst estimates for the fifth consecutive quarter.
The Motley Fool February 10, 2006 Dan Bloom	OSI Systems' Rays of Hope Things may improve over the next two years for the technology conglomerate's Rapiscan division. Investors, take note.
The Motley Fool April 28, 2009 Rich Smith	General Electric Loses Its Vision GE will sell its Homeland Protection unit to French technology group SAFRAN. And in a few months, it will lose InVision and Ion Track, too.
The Motley Fool August 10, 2010 Rich Smith	Like Kryptonite for Super Bankers AS&E makes Wall Street look small-f foolish. Yesterday, American Science & Engineering gave investors an object lesson in Wall Street "analysis."
The Motley Fool May 12, 2011 Rich Smith	American Science and Bad Forecasting Wall Street can't get this one right -- don't you make the same mistake.
The Motley Fool May 18, 2009 Rich Smith	American Science Sinks Things could get even better for AS&E, as the Obama administration seems more likely to increase than decrease funding for port and airport security -- AS&E's forte.
InternetNews October 16, 2007 Sean Michael Kerner	Microsoft: The Open Source Company Microsoft joins the open source community today with the blessing of the Open Source Initiative.
The Motley Fool July 2, 2008 Rich Smith	American Science & Wow! American Science & Engineering, maker of high-tech X-ray machines, announces one of the biggest contracts it's ever reported.
The Motley Fool November 10, 2010 Rich Smith	When Is a Spike in Terrorism "Good News"? Answer: Whenever American Science & Engineering reports earnings.
The Motley Fool August 8, 2007 Rich Smith	American Shazam & Engineering Investors, American Science & Engineering's numbers are stunning. But it's hard to tell why.
The Motley Fool May 14, 2008 Rich Smith	AS&E Delivers American Science & Engineering's most recent quarterly report makes three straight quarters of year-over-year profit declines.
The Motley Fool February 9, 2006 Dan Bloom	American Science & Engineering in a Sweet Spot Business is booming for this manufacturer of X-ray security devices. Short sellers of this stock, beware.
The Motley Fool May 1, 2006 Stephen D. Simpson	Might SYSCO Be Worth a Nibble? Even though SYSCO may have again lost a little share, this is a company with some pretty solid fundamentals behind it. Is there actual value in this stock?
The Motley Fool February 9, 2011 Rich Smith	Time to Sell American Science & Engineering? When do strong earnings signal "sell"? When numbers like these at this defense company make investors feel just a tiny bit nervous.
The Motley Fool June 6, 2006 Nathan Parmelee	OSI Has a Pirate On Board Pirate Capital urges OSI Restaurant Partners to speed up its shareholder value initiatives or prepare for a proxy battle. A little outside pressure can help to focus management on moving more quickly and also highlight the need to deliver on promises.
The Motley Fool June 28, 2006 Nathan Parmelee	Cheesecake Factory Crumbles Cheesecake Factory warns that same-store sales will be flat to slightly negative. Investors, should you care?
The Motley Fool August 3, 2007 Rich Smith	Foolish Forecast: AS&E Fills Its Dance Card The X-ray-detection specialist American Science & Engineering is set to release its first-quarter 2008 financial results. Investors, here is what you can expect to see.
The Motley Fool February 10, 2009 Rich Smith	American Science's Miracle Quarter Once again, American Science & Engineering walloped the Street's earnings estimates. The impressive set of Q3 numbers included a 163% leap in profits.
The Motley Fool August 1, 2006 Jim Mueller	Texas Roadhouse's Softening The restaurant lowers guidance and the stock sells off, but why?
The Motley Fool October 29, 2007 Billy Fisher	Tarceva Sales Thrive at OSI The pharmaceutical's net revenue jumps 77%. Amazingly enough, there's still room for further growth at OSI. Investors, take note.
The Motley Fool May 3, 2007 Billy Fisher	Optimism for OSI With Tarceva sales growing across the board and the potential for new uses on the horizon, coupled with a shrewd divestiture of an unprofitable product, the general outlook for OSI appears to be quite favorable. Investors, take note.
InternetNews February 1, 2005 Michael Singer	OSI President Eric Raymond Steps Down The open source licensing group to expand the scope of its activities, with new board members.
The Motley Fool January 12, 2007 Matthew Crews	OSI: A Farewell Toast OSI Restaurant partners reports its last quarterly earnings before going private.
The Motley Fool May 23, 2011 Rich Smith	Investing Post-Osama Congress lets its guard down, lowering investors' hopes in the process.
The Motley Fool February 11, 2010 Rich Smith	American Science Takes Its Lumps Once again, AS&E suffers from lumpy earnings.
The Motley Fool November 6, 2009 Rich Smith	American Science Does It Again AS&E reported fiscal-second-quarter results. Judging from the stock price, investors have gone wild -- and rightly so.
The Motley Fool November 6, 2006 Nathan Parmelee	Outback Offer a Little Underdone OSI Restaurant Partners' offer to go private for $40 a share is reasonable, but not great. Here's why.
The Motley Fool May 8, 2006 Dan Bloom	Why the Short Interest in AS&E? We examine the possible reasons behind the interest in short positions on American Science & Engineering. If you get nervous seeing red in your portfolio, then you should consider selling now and watch this one from the sidelines.
The Motley Fool November 1, 2010 Rich Smith	Bomb Detection Just Got More Interesting The latest foiled terror plot catches investors' interest and may highlight the higher costs of doing business for both UPS and FedEx.
The Motley Fool May 5, 2005 Charly Travers	OSI's Cancer Blockbuster Tarceva will turn OSI Pharmaceuticals into a leading biotech.
InternetNews August 9, 2007 Sean Michael Kerner	Does Open Source Licensing Matter? According to a panel at LinuxWorld, licensing may not matter at all.
The Motley Fool February 27, 2007 Billy Fisher	OSI Eyeing Growth in '07 Despite recent mixed results, the pharmaceutical has higher hopes for the year. Investors, take note.
The Motley Fool August 1, 2007 Billy Fisher	Overseas Growth Sparks OSI's Earnings OSI Pharmaceuticals continues to prosper, and it has Tarceva to thank. But what happens when Tarceva becomes obsolete around 2009? Investors, take note.
The Motley Fool May 14, 2007 Tom Taulli	Investors Grilling Outback Steakhouse Public shareholders are trying to get a higher bid from the restaurant chain.
The Motley Fool July 14, 2004 Dave Marino-Nachison	Red Robin is Flying High Price increases and store-level efficiency improvements are boosting the burger chain Red Robin.
The Motley Fool August 1, 2007 Rich Smith	L-3 Overtaken by Events Three recent contract awards from the U.S. government which may hold even more promise for L-3's future than did the news that management raised guidance last week. Why is it, again, that L-3 is down 3% post-earnings?
The Motley Fool December 5, 2006 Rick Aristotle Munarriz	Wishing on a Star, Steak Lovers Lone Star's stock closed at $23.55 the day before the buyout offer. Since then, crippling comps and sharply reduced profit forecasts have only crumbled the already iffy fundamentals. If there is a better bid out there, great. If not, look out below.
InternetNews August 17, 2007 Sean Michael Kerner	Stop Whining: Let's All Be (C)PALS New open source license draws converts to Open Source Initiative approval.
The Motley Fool May 21, 2007 Ryan Fuhrmann	Foolish Forecast: Cracker Barrel Paves a Simpler Road CBRL, the holding company for Cracker Barrel Old Country Stores, is set to report its recent quarterly report. Investors, here is what you can expect to see.
The Motley Fool August 22, 2005 Rich Duprey	Fuzzy Outlook for OSI-Eyetech Merger OSI Pharmaceuticals appears to have little to gain from its purchase of Eyetech. The situation does offer an eye-opening lesson on the risks inherent in investing in such one-trick ponies.
Military & Aerospace Electronics February 2010	OSI Geospatial to Deliver Counter-IED Training Solution to Defense Research and Development Canada OSI will provide a Counter-IED Immersive Training Environment (CIITE) system using the company's iGEN Cognitive Synthetic Agents.
The Motley Fool May 17, 2007 Timothy M. Otte	Outback Buyout Deal Underdone? Steakhouse chain delays shareholder vote again. Will management be able to round up a majority of shareholders to vote the deal at $40 per share?
The Motley Fool May 26, 2006 Dan Bloom	What's Next for AS&E? The bulls and bears continue to their tussle over American Science & Engineering. Uncertainty is unavoidable in investing, but if you own this stock, you can take comfort in the fact that the potential gain is much larger than the potential loss.
The Motley Fool June 21, 2011 Seth Jayson	A Hidden Reason Why the Future Looks Bright for OSI Systems Although OSI Systems shows inventory growth that outpaces revenue growth, the company may also display positive inventory divergence, suggesting that management sees increased demand on the horizon.
The Motley Fool May 1, 2006 Nathan Parmelee	OSI Weighs Its Options The restaurant partnership could pursue many courses to unlock shareholder value. While performance came in slightly lower than expected, it also wasn't a large disappointment. Investors, take note.
InternetNews August 23, 2005 Jim Wagner	OSI's Open Flap The goals of the Open Source initiative's license proliferation committee were thrown into question when the creator of the organization's manifesto, Bruce Perens, was recently denied entrance.